| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,753 |
36,318 |
$1.49M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
4,317 |
3,400 |
$1.09M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,034 |
16,590 |
$919K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,215 |
1,143 |
$414K |
| 99215 |
Prolong outpt/office vis |
2,531 |
1,995 |
$167K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,808 |
23,513 |
$143K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,670 |
1,410 |
$103K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,515 |
2,221 |
$70K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,436 |
1,924 |
$65K |
| 80050 |
General health panel |
2,083 |
1,937 |
$60K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
880 |
831 |
$58K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,611 |
6,252 |
$55K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
573 |
520 |
$53K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,795 |
2,567 |
$36K |
| 80061 |
Lipid panel |
4,551 |
3,942 |
$33K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
483 |
478 |
$33K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,615 |
2,260 |
$31K |
| 71046 |
Radiologic examination, chest; 2 views |
1,849 |
1,661 |
$30K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
456 |
440 |
$28K |
| 84439 |
|
4,102 |
3,483 |
$23K |
| 81000 |
|
8,145 |
7,039 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,693 |
3,131 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
505 |
448 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
504 |
447 |
$16K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
503 |
446 |
$15K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
208 |
195 |
$15K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,192 |
1,032 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
947 |
845 |
$12K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
221 |
192 |
$12K |
| 87634 |
|
243 |
218 |
$12K |
| 81025 |
|
2,255 |
1,896 |
$12K |
| 92551 |
|
1,489 |
1,436 |
$12K |
| 80053 |
Comprehensive metabolic panel |
3,726 |
3,162 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,191 |
6,744 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,765 |
1,532 |
$9K |
| 74018 |
|
595 |
545 |
$9K |
| 83735 |
|
2,101 |
1,677 |
$9K |
| 85004 |
|
1,348 |
1,160 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
145 |
127 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
4,077 |
3,542 |
$7K |
| 83970 |
|
298 |
255 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
121 |
102 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
379 |
341 |
$4K |
| 82043 |
|
1,060 |
938 |
$3K |
| 99173 |
|
1,546 |
1,479 |
$3K |
| 90686 |
|
337 |
323 |
$3K |
| 82570 |
|
826 |
734 |
$2K |
| 84436 |
|
1,480 |
1,355 |
$2K |
| 84479 |
|
1,480 |
1,355 |
$2K |
| G0181 |
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans |
94 |
92 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
149 |
73 |
$2K |
| 82607 |
|
178 |
161 |
$1K |
| 82746 |
|
174 |
159 |
$1K |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$1K |
| 86308 |
|
252 |
244 |
$1K |
| 99490 |
Ccm add 20min |
408 |
405 |
$1K |
| 84153 |
|
77 |
67 |
$915.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,005 |
5,906 |
$666.09 |
| 72100 |
|
27 |
27 |
$612.25 |
| 82441 |
|
158 |
144 |
$501.48 |
| 77080 |
|
15 |
14 |
$492.16 |
| 93000 |
|
48 |
36 |
$426.27 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$327.72 |
| 90474 |
|
41 |
36 |
$292.16 |
| 87400 |
|
34 |
15 |
$286.50 |
| 73560 |
|
13 |
12 |
$221.04 |
| 84550 |
|
56 |
55 |
$206.54 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,325 |
1,856 |
$199.48 |
| 82728 |
|
12 |
12 |
$121.95 |
| 86200 |
|
17 |
14 |
$100.24 |
| 90715 |
|
27 |
27 |
$98.64 |
| 83550 |
|
12 |
12 |
$78.39 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
18 |
15 |
$47.25 |
| 3078F |
|
75 |
73 |
$43.00 |
| 3074F |
|
85 |
82 |
$40.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
49 |
42 |
$18.79 |
| 3079F |
|
24 |
24 |
$10.00 |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
110 |
92 |
$1.26 |
| 90633 |
|
339 |
299 |
$0.34 |
| 90651 |
|
49 |
49 |
$0.03 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,646 |
1,293 |
$0.00 |
| 90697 |
|
69 |
63 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
897 |
726 |
$0.00 |
| 90620 |
|
14 |
13 |
$0.00 |
| 90619 |
|
38 |
37 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
116 |
116 |
$0.00 |
| 90723 |
|
122 |
117 |
$0.00 |
| 90680 |
|
88 |
84 |
$0.00 |
| 90670 |
|
591 |
573 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,889 |
3,083 |
$0.00 |
| G8539 |
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment |
984 |
689 |
$0.00 |
| 90671 |
|
117 |
92 |
$0.00 |
| 90734 |
|
56 |
52 |
$0.00 |
| 90648 |
|
339 |
312 |
$0.00 |
| 90710 |
|
33 |
28 |
$0.00 |
| 90662 |
|
45 |
45 |
$0.00 |
| 90658 |
|
77 |
69 |
$0.00 |